IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
Autor: | D. V. Nebieridze, T. V. Kamyshova |
---|---|
Jazyk: | English<br />Russian |
Rok vydání: | 2015 |
Předmět: | |
Zdroj: | Рациональная фармакотерапия в кардиологии, Vol 8, Iss 2, Pp 233-236 (2015) |
Druh dokumentu: | article |
ISSN: | 1819-6446 2225-3653 |
DOI: | 10.20996/1819-6446-2012-8-2-233-236 |
Popis: | The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin resistance, endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considered. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |